Adaptimmune SURPASS

Clinical Trial Grant

Duke Scholars

Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

October 14, 2019

End Date

October 21, 2022

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

October 14, 2019

End Date

October 21, 2022